Clinical Trial Update: Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates safety issues for botulinum toxin type A block of the sphenopalatine ganglion in trigeminal neuralgia, presented as Phase 1/2 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache Disorders
• Trigeminal Neuralgia

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Trigeminal Neuralgia, Headache Disorders | Phase 1, Phase 2 | Status: COMPLETED